CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.53
−3.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 87.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 114.88x
- Price / sales
- 7.05x
- Price / cash flow
- -5.30x
Enterprise value
- Enterprise value
- $256.8M
- EV / sales
- 6.82x
- EV / EBITDA
- -2.68x
- EV / EBIT
- -2.60x
- Market cap
- $265.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026